Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

Gomez Cadena, Alejandra; Spehner, Laurie; Kroemer, Marie; Khelil, Myriam Ben; Bouiller, Kevin; Verdeil, Grégory; Trabanelli, Sara; Borg, Christophe; Loyon, Romain; Jandus, Camilla

doi:10.1038/s41423-020-00596-2

Scientific article

English

Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

ContributorsGomez Cadena, Alejandra; Spehner, Laurie; Kroemer, Marie; Khelil, Myriam Ben; Bouiller, Kevin; Verdeil, Grégory; Trabanelli, Sara; Borg, Christophe; Loyon, Romain; Jandus, Camilla

Published inCellular & Molecular Immunology, vol. 18, no. 2, p. 484-486

Publication date2021

Keywords

COVID-19/blood/immunology/pathology
Humans
Immunity
Innate
Interleukin-33/metabolism
Lymphocytes/immunology
NK Cell Lectin-Like Receptor Subfamily K/metabolism

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Research groups

Ciblage des lymphocytes sécrétant des cytokines (1015)

Funding

Swiss National Science Foundation - PRIMA PR00P3_179727

Citation (ISO format)

GOMEZ CADENA, Alejandra et al. Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment. In: Cellular & Molecular Immunology, 2021, vol. 18, n° 2, p. 484–486. doi: 10.1038/s41423-020-00596-2

Article (Published version)

CC BY

Supplemental data

CC BY

Identifiers

PID : unige:151644
DOI : 10.1038/s41423-020-00596-2
PMID : 33318627

Journal ISSN1672-7681

248views

145downloads

Creation07/05/2021 15:40:00

First validation07/05/2021 15:40:00

Update16/03/2023 00:34:20

Status update16/03/2023 00:34:19

Last indexation31/10/2024 22:05:33

Archive ouverte UNIGE

Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

Technical informations